News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
380,163 Results
Type
Article (26354)
Company Profile (113)
Press Release (353696)
Section
Business (105623)
Career Advice (556)
Deals (17216)
Drug Delivery (46)
Drug Development (47798)
Employer Resources (48)
FDA (12284)
Job Trends (8628)
News (188092)
Policy (19714)
Tag
Academia (1761)
Allergies (51)
Alliances (26929)
Alzheimer's disease (725)
Approvals (12245)
Artificial intelligence (86)
Bankruptcy (141)
Best Places to Work (6956)
Biotechnology (76)
Breast cancer (87)
Cancer (698)
Cardiovascular disease (74)
Career advice (502)
Cell therapy (122)
Clinical research (39545)
Collaboration (224)
COVID-19 (1477)
C-suite (56)
Data (772)
Diabetes (99)
Diagnostics (3409)
Earnings (36364)
Events (51253)
Executive appointments (202)
FDA (12708)
Funding (188)
Gene therapy (77)
GLP-1 (325)
Government (3070)
Healthcare (12288)
Infectious disease (1523)
Inflammatory bowel disease (65)
Interviews (60)
IPO (7115)
Job creations (1932)
Job search strategy (455)
Layoffs (162)
Legal (3688)
Lung cancer (128)
Manufacturing (70)
Medical device (12740)
Medtech (12743)
Mergers & acquisitions (10177)
Metabolic disorders (259)
Neuroscience (900)
NextGen Class of 2024 (4012)
Non-profit (2920)
Northern California (779)
Obesity (150)
Opinion (76)
Patents (55)
People (34478)
Phase I (11291)
Phase II (17153)
Phase III (14078)
Pipeline (272)
Postmarket research (1668)
Preclinical (3555)
Radiopharmaceuticals (156)
Rare diseases (114)
Real estate (3071)
Regulatory (13863)
Research institute (1624)
Resumes & cover letters (60)
Southern California (681)
Startups (2157)
United States (7680)
Vaccines (301)
Weight loss (110)
Date
Today (1)
Last 7 days (392)
Last 30 days (2001)
Last 365 days (20458)
2024 (18747)
2023 (23098)
2022 (31037)
2021 (33374)
2020 (32604)
2019 (28969)
2018 (22290)
2017 (19136)
2016 (18405)
2015 (21489)
2014 (16273)
2013 (13542)
2012 (14620)
2011 (14982)
2010 (13405)
Location
Africa (386)
Arizona (92)
Asia (24508)
Australia (3876)
California (1722)
Canada (788)
China (171)
Colorado (92)
Connecticut (97)
Delaware (51)
Europe (47914)
Florida (294)
Georgia (75)
Illinois (230)
Indiana (138)
Kansas (69)
Maryland (428)
Massachusetts (1245)
Michigan (105)
Minnesota (180)
New Hampshire (53)
New Jersey (617)
New York (541)
North Carolina (405)
Northern California (779)
Ohio (90)
Pennsylvania (529)
South America (551)
Southern California (681)
Texas (288)
Washington State (144)
380,163 Results for "silk road medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.
June 18, 2024
·
7 min read
Deals
Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
Silk Road Medical, Inc. announced it has entered into a definitive agreement to be acquired by Boston Scientific Corporation, a global medical technology leader, for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.
June 18, 2024
·
7 min read
Business
Silk Road Medical Reports First Quarter 2024 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2024.
April 30, 2024
·
8 min read
Biotech Bay
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2024 Healthcare Conference.
April 23, 2024
·
1 min read
Press Releases
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
September 17, 2024
·
5 min read
Business
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, April 30th, 2024.
April 9, 2024
·
1 min read
Biotech Bay
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE® Transcarotid Neuroprotection System PLUS (“NPS PLUS”), a key component of the TCAR® portfolio.
April 2, 2024
·
3 min read
Biotech Bay
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.
March 5, 2024
·
3 min read
Business
Silk Road Medical Reports Second Quarter 2024 Financial Results
August 7, 2024
·
8 min read
Business
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.
February 28, 2024
·
10 min read
1 of 38,017
Next
